Biotech firm Graft Polymer said on Monday that it has agreed to buy Awakn Life Sciences Corp, a clinical-stage biotechnology ...

Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) announced it would be bought by Graft Polymer (UK) PLC with Graft ...

Awakn Life Sciences (TSE:AWKN) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ...

Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology ...

Graft Polymer (UK) PLC (LSE:GPL) is buying Awakn Life Sciences Corp in an all-paper deal worth £4.98 million, expanding its interest in the fields of mental health and addiction. Awakn, a Canadian ...

Graft Polymer (UK) Plc plans to rebrand as Solvonis Therapeutics Plc, aligning its identity with a strategic focus on mental health and substance use disorder treatments. The company highlights ...

Graft Polymer (UK) PLC (GB:GPL) has released an update. Graft Polymer (UK) Plc plans to rebrand as Solvonis Therapeutics Plc, aligning its identity with a strategic focus on mental health and ...

Graft Polymer (UK) PLC (LSE:GPL) has announced encouraging initial findings from a pre-clinical study of AW21003, a compound being developed with Awakn Life Sciences to treat trauma-related mental ...